Vestmark Advisory Solutions, Inc. Insulet Corp Transaction History

Vestmark Advisory Solutions, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$272.48 - $330.23 $193,460 - $234,463	-710 Reduced 18.62%	3,103 $894,000
Q1 2023 May 09, 2023	BUY	$276.36 - $326.03 $186,819 - $220,396	676 Added 21.55%	3,813 $1.22 Million
Q4 2022 Jan 20, 2023	SELL	$212.22 - $313.46 $12,520 - $18,494	-59 Reduced 1.85%	3,137 $0
Q3 2022 Nov 03, 2022	BUY	$224.6 - $281.45 $61,540 - $77,117	274 Added 9.38%	3,196 $733,000
Q2 2022 Aug 04, 2022	BUY	$186.4 - $279.02 $70,832 - $106,027	380 Added 14.95%	2,922 $637,000

Q1 2022 Apr 27, 2022	BUY	$194.8 - $275.7 $291,226 - $412,171	1,495 Added 142.79%	2,542 $677,000
Q4 2021 Jan 31, 2022	BUY	$255.32 - $318.29 $267,320 - $333,249	1,047 New	1,047 $279,000

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.